Slides
Page 1
ADAMA Agricultural Solutions Ltd Third Quarter & First Nine Months 2026 Financial Performance
Page 2
Legal Notice 2 This presentation is for marketing and information purposes only. By this presentation, neither ADAMA Ltd. nor ADAMA Agricultural Solutions Ltd. (together the “Company” or “ADAMA”) intend to give, and the presentation does not constitute, professional or business advice or an offer or recommendation to perform any transaction in the Company’s securities. The accuracy, completeness and/or adequacy of the content of this presentation, as well as any estimation and/or assessment included in this presentation, if at all, is not warranted or guaranteed and the Company disclaims any intention and/or obligation to comply with such content. The Company may make improvements and/or changes in the features or content presented herein at any time. The Company shall not be liable for any loss, claim, liability or damage of any kind resulting from your reliance on, or reference to, any detail, fact or opinion presented herein. This presentation contains proprietary information of the Company and may not be reproduced, copied, disclosed or utilized in any way, in whole or in part, without the prior written consent of the Company. The Company’s assessments may not materialize, inter alia, due to factors out of the Company's control, including the risk factors listed in the Company’s annual reports, changes in the industry or potential operations of the Company's competitors. All information included in this presentation relates only to the date which it refers to, and the Company does not undertake to update such information afterwards. Any content contained herein shall not constitute or be construed as any regulatory, valuation, legal, tax, accounting and investment advice or any advice of any kind or any part of it. Nor shall they constitute or be construed as any recommendation, solicitation, offer or commitment (or any part of it) to buy, sell, subscribe for or underwrite any securities, provide any credit or insurance or engage in any transactions. Without any written consent, any third party providing this document to you shall not act as your financial advisor or trustee. Before entering into any transactions, you shall ensure that you fully understand the potential risks and returns of such transactions. Before making such decisions, you shall consult the advisors you think necessary, including your accountant, investment advisor and legal and tax specialists. The Company and its affiliates, controlling persons, directors, officials, partners, employees, agents, representatives or their advisors shall not assume any responsibilities of any kind (including negligence or others) for the use of and reliance on such information by you or any person to whom such information are provided.
Page 3
3 Q3 & 9M 2026 Highlights • The ongoing market trends from the beginning of the year continued, while in Q3 the performance was impacted by significant weather disruption in Europe and by elevated costs: • Pricing pressure continued, particularly in the off-patent market • Good commercial performance in Europe built strong momentum in H1, in Q3 the record-breaking heat and drought led to lower overall volumes, which negatively impacted sales and regional mix • Cost increased in Q3 following the volatility caused by geo- political tensions • Performance in key markets and product categories confirms strategic direction • Improved product mix in both Q3 & 9M 2026 • Continued OPEX discipline despite inflationary environment and negative FX, Q3’26 OPEX -$8m below PY • Continued decreased financial expenses due to improved debt profile and cash management * PY – previous year
Page 4
ADAMA Solutions Q3 2026 Adjusted $ million Q3 2026 Q3 2025 %▲ Sales 809 853 (5%) Gross Profit 205 242 (15%) % of Sales 25.3% 28.3% EBITDA 66 96 (31%) % of Sales 8.2% 11.3% Net Loss (79) (22) % of Sales (9.8%) (2.6%) Reported Net Loss (117) (42) (14.5%) (4.9%) * PY – previous year There may be some difference in percentages due to rounding 4 Highlights ▪ Sales declined 5% to $809 million ̶ 4% lower volumes and 3% lower prices vs. PY ̶ Lower volumes resulting from lower market demand in certain regions due to higher farmer costs and weather conditions compensated by new product introductions. Lower prices reflected the overall lower market pricing and weaker farmer purchasing power. ▪ Gross Profit 15% below Q3’25; Gross Margin of 25.3% vs. 28.3% PY ̶ Lower volume and prices, as well as higher cost more moderated by improved mix and favorable foreign exchange ▪ EBITDA amounted to $66 million 31% below Q3’25; EBITDA Margin of 8.2%, vs. 11.3% PY ̶ Lower OPEX mainly due to tight OPEX control despite FX headwinds ▪ Adjusted Net Loss of $79m vs. $22m PY ̶ Despite lower financial expenses positively impacted by the CPI, improved overall loan terms, the benefit of the continued positive cash flow and lower hedging costs
Page 5
ADAMA Solutions 9M 2026 Adjusted $ million 9M 2026 9M 2025 %▲ Sales 2,740 2,698 2% Gross Profit 777 788 (1%) % of Sales 28.4% 29.2% EBITDA 305 341 (11%) % of Sales 11.1% 12.6% Net Loss (34) (1) % of Sales (1.2%) 0.0% Reported Net Loss (72) (76) (2.6%) (2.8%) * PY – previous year There may be some difference in percentages due to rounding 5 Highlights ▪ Sales increased 2% to $2,740 million ̶ 2% higher volume and 4% lower prices vs. PY ̶ Higher volumes reflecting market demand supported by new product introductions. Lower prices reflected the overall lower market pricing and weaker farmer purchasing power ▪ Gross Profit 1% below 9M’25; Gross Margin of 28.4% vs. 29.2% PY ̶ Lower prices and higher costs moderated by higher volumes, improved mix and favorable exchange rates ▪ EBITDA amounted to $305 million 11% below 9M’25; EBITDA Margin of 11.1%, vs. 12.6% PY ̶ Higher OPEX reflecting the negative impact of exchange rates, an increase in employee compensation and an increase in the first half of 2026 in expenses supporting business growth. ▪ Adjusted Net Loss of $34m vs. $1m PY ̶ Despite lower financial expenses reflecting better debt structure also reflecting bond buy back in Q2 2025, favorable CPI impact of positive cash flow and lower FX hedging costs.
Page 6
Regional Sales Performance Q3 2026 vs. Q3 2025 % Sales growth by region Total sales & absolute change in sales ($m) • CER - Constant Exchange Rates • APAC includes ADAMA India; LATAM includes Brazil (14%) 7% (8%) 2% (5%) (17%) 7% (12%) 5% (7%) Europe, Africa & Middle East North America Latin America Asia Pacific Total USD CER (32) 11 (26) 3 (44) 199 174 151 809 286 6
Page 7
Regional Sales Performance 9M 2026 vs. 9M 2025 % Sales growth by region Total sales & absolute change in sales ($m) 920 690 490 2,740 639 • CER - Constant Exchange Rates • APAC includes ADAMA India; LATAM includes Brazil 7 3% 6% (5%) 2% 2% (3%) 6% (10%) 4% (1%) Europe, Africa & Middle East North America Latin America Asia Pacific Total USD CER 27 39 (36) 12 42
Page 8
Regional Highlights 8 • CER – Constant Exchange Rates • APAC – Asia Pacific • EAME – Europe, Africa & Middle East • LATAM – Latin America LATAM Brazil • Sales declined despite intensified commercial execution ahead of the soybean season particularly across fungicides and insecticides. • Continued pricing pressure, farmer liquidity constraints and intense competition, particularly in commodity products. LATAM • Sales increased supported by higher volumes, particularly in Argentina, and commercial momentum across key markets. • Continued competitive and pricing pressure and El-Niño impact in certain countries. • Sales supported by growth across Professional Solutions, Consumer and Canada. • US Ag was impacted by lower market prices mainly in commodity categories. • Pricing pressure and elevated inventories affected several US agricultural products. EAME APAC • Sales increased supported by growth in Pacific and India more than offsetting a decline in other South-East Asia sales. • Pacific benefited from fungicide demand in Southern and Western Australia supported by new product introductions. • South-East Asia sales were impacted by El-Niño. 2% 4% 9M $ CER North America 3% -3% 9M $ CER -5% -10% 9M $ CER 6% 6% 9M $ CER 7% 7% Q3 $ CER -8% -12% Q3 $ CER -14% -17% Q3 $ CER 2% 5% Q3 $ CER • Sales declined in the third quarter reflecting significantly weaker market consumption and lower crop-protection applications across several European markets due to weather impacts creating channel inventory build- up and due to elevated farmer input costs. • Market-share gains partly mitigated the decline • Competitive and pricing pressure remained high, concentrated in specific off- patent active ingredients.
Page 9
Sales bridge analysis Q3 Sales Notes – Numbers in million $; Denotes adjusted figures unless otherwise noted; Parts may not sum due to rounding; FX includes currency effect on sales, net of hedging.9 853 -35 -23 14 809 Q3 2025 ∆ Volumes ∆ Prices FX Q3 2026 -5%-3% -4% ▪ Lower volumes resulting from lower market demand in certain regions due to higher farmer costs and weather conditions compensated by new product introductions. ▪ Lower prices reflected the overall lower market pricing and weaker farmer purchasing power.
Page 10
Q3 Gross Profit & EBITDA Notes – Numbers in million $; Denotes adjusted figures unless otherwise noted; Parts may not sum due to rounding; Volumes include mix effect; FX includes currency effect on sales and costs and opex, net of hedging10 242 -3 -23 -21 10 205 Q3 2025 ∆ Volumes ∆ Prices ∆ Cost FX Q3 2026 28.3% 25.3% 31% 96 -23 -21 10 7 66-3 Q3 2025 ∆ Volumes ∆ Prices ∆ Cost ∆OPEX FX Q3 2026 15% 11.3% 8.2% Gross Profit bridge analysis Reflecting lower volume and prices, as well as higher cost more than offsetting improved quality of the business and favorable foreign exchange EBITDA bridge analysis Lower OPEX mainly due to tight OPEX control, despite negative exchange rate impact on OPEX
Page 11
9M Sales Notes – Numbers in million $; Denotes adjusted figures unless otherwise noted; Parts may not sum due to rounding; FX includes currency effect on sales, net of hedging.11 Sales bridge analysis 2,698 65 -101 78 2,740 9M 2025 ∆ Volumes ∆ Prices FX 9M 2026 2% ▪ Higher volumes reflecting stronger H1 market demand ▪ Lower prices reflecting overall weaker market prices and weaker farmer purchasing power -4% 2%
Page 12
9M Gross Profit & EBITDA Notes – Numbers in million $; Denotes adjusted figures unless otherwise noted; Parts may not sum due to rounding; Volumes include mix effect; FX includes currency effect on sales and costs and opex, net of hedging 12 788 -101 -23 67 77747 9M 2025 ∆ Volumes ∆ Prices ∆ Cost FX 9M 2026 29.2% 28.4% -11% 341 -101 -20 -4 42 305 47 9M 2025 ∆ Volumes ∆ Prices ∆ Cost ∆OPEX FX 9M 2026 -1% 12.6% 11.1% Gross Profit bridge analysis Higher volumes and improved quality of the business as well as favorable foreign exchange, more than offset by lower prices and cost increase EBITDA bridge analysis Higher OPEX reflecting the negative impact of exchange rates, an increase in employee compensation and an increase in the first half of 2026 in expenses supporting business growth.
Page 13
13 Unit: million USD * △ in comparison to Q1 2026 74 61 9M 2025 9M 2026 157 90 9M 2025 9M 2026 Operating Cash Flow Free Cash Flow Cash Flow Lower collections due to timing difference in Q1’25 and lower procurement in comparison to last year, in which the Company increased procurement and inventory in order to provide business continuity during the merging of entities in Israel. Impact on free cash flow was moderated due to continued ROI-based investment discipline and proceeds from sale of fixed assets, mainly a logistics center in Israel
Page 14
Effective Interest Rate Sep 30, 2026 in Million USD 5. 64%196 Short-term loans and credit from banks and commercial papers 5.03%490Short-term loans from related parties 2.69%113Long-term loans from banks (including current maturities) 4.98%345Long-term loans from related parties (including current maturities) 5.15%+CPI814Debentures (ILS denominated) (including current maturities) 1,958Total Debt Breakdown: ADAMA Solutions 14 As of September 30, 2026, the Company has unused committed credit lines from banks (of approximately $317m), and unused committed credit lines from related parties (of approximately $260m). Short-TermLong-Term Syngenta short term 28% Short term bank loans 10% Long Term Bank Loans 6% Syngenta long term 15% Bonds 41% Total debt as of 30.09.2026: $1,958m
Page 15
Net Debt/EBITDA ratio 15 * Net Debt for bank covenant purposes excludes securitization and SG loans; including $ 835m SG loans the ratio would be 3.6 Net Debt/EBITDA ratio 1.8X 815 460 Net Debt* 30/09/26 Last 12 mo. EBITDA
Page 16
THANK YOU
Page 17
Adjusted vs. Reported P&L *The adjusted gross profit includes all inventory impairment and excludes certain transportation costs, which are included in the reported cost of goods. 17 $ million Q3 2026 Adjusted Q3 2025 Adjusted %▲ Q3 2026 Reported Q3 2025 Reported %▲ 9M 2026 Adjusted 9M 2025 Adjusted %▲ 9M 2026 Reported 9M 2025 Reported %▲ Sales 809 853 (5%) 809 853 (5%) 2,740 2,698 2% 2,740 2,698 2% Gross Profit 205 242 (15%) 201 242 (17%) 777 788 (1%) 768 780 (1%) % of Sales 25.3% 28.3% 24.8% 28.3% 28.4% 29.2% 28.0% 28.9% EBITDA 66 96 (31%) 62 86 (27%) 305 341 (11%) 329 299 10% % of Sales 8.2% 11.3% 7.7% 10.0% 11.1% 12.6% 12.0% 11.1% Net Loss (79) (22) (117) (42) (34) (1) (72) (76) % of Sales (9.8%) (2.6%) (14.5%) (4.9%) (1.2%) 0.0% (2.6%) (2.8%)
Page 18
Adjusted vs. Reported Financial Results Note: “Others” included accelerated depreciation, other financing expenses and tax impacts. Please see appendix to 2026 Second Quarter Report for more details. 18 The financial results in this presentation are presented on an “Adjusted” basis, and differ to some extent from the “Reported” financials contained in the formal financial statements of the Company. ADAMA’s approach on the use of adjustments: • Adjusted results: • Exclude items that are of a one-time or non-cash/non-operational nature that do not impact the ongoing performance of the business • Reflect the way the Company’s management and the Board of Directors view the performance of the Company internally • The Company believes that excluding the effects of these items from its operating results allows management and investors to effectively compare the true underlying financial performance of its business from period to period and against its global peers 9M 259M 26Q3 25Q3 26$ million (76)(72)(42)(117)Reported Net Loss 161655Amortization of Transfer assets received and written-up due to 2017 CC-SYT transaction (non-cash) 8733Amortization of acquisition-related PPA (non-cash) and other acquisition related costs -(36)--Capital gain from sale of a subsidiary's logistics center in Israel 3512116Restructuring costs 7---Cleanup and remediation costs for plants in Israel 135123Fixed assets and inventory impairment -(2)-(2)Compensation related to product liability 86-3Others 75381938Total adjustments to net profit (1)(34)(22.5)(79)Adjusted Net Loss